BARD noninvasive prediction score for advanced fibrosis in nonalcoholic fatty liver
[select name="Q1" value="no (0 points)=0|YES (1 point)=1"] <-- BMI: 28 or higher
[select name="Q2" value="no (0 points)=0|YES (2 point)=2"] <-- AST to ALT Ratio (AAR): 0.8 or higher
[select name="Q3" value="no (0 points)=0|YES (1 point)=1"] <-- Type 2 Diabetes Mellitus
score --> [calc memo="number" value="score1=(Q1)+(Q2)+(Q3)"]
interpretation --> [calc memo="result" value="score2=(Q1)+(Q2)+(Q3);score2>1?'Advanced fibrosis is possible, further evaluation may be needed':'Advanced fibrosis is unlikely, negative predictive value of score is 90-97%'"]
[html]<hr>[/html][checkbox memo="display/hide footnotes" name="footnotes" value=""][conditional field="footnotes" condition="(footnotes).is('')"][html]
reference:  <a href="http://www.ncbi.nlm.nih.gov/pubmed/18390575" target="_blank">Harrison SA, Oliver D, Arnold HL, Gogia S, Neuschwander-Tetri BA. Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease. Gut. 2008 Oct;57(10):1441-7.</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed/20584330" target="_blank">Raszeja-Wyszomirska J, Szymanik B, ≈Åawniczak M, Kajor M, Chwist A, Milkiewicz P, Hartleb M. Validation of the BARD scoring system in Polish patients with nonalcoholic fatty liver disease (NAFLD). BMC Gastroenterol. 2010 Jun 28;10:67.</a>
posted by:  Mark Morgan, M.D.
post/review dates:  October 6, 2014; August 24, 2015
permalink: <a href="http://www.soapnote.org/digestive-system/bard/" target="_blank">www.soapnote.org/digestive-system/bard/</a>
markup link:  <a href="http://www.soapnote.org/generator/txt/digestive-system/bard.txt" target="_blank">www.soapnote.org/generator/txt/digestive-system/bard.txt</a>[/html][/conditional]
